Tissue-removing catheter with guidewire isolation liner
US-12114887-B2 · Oct 15, 2024 · US
US10125159B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10125159-B2 |
| Application number | US-201715610269-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 31, 2017 |
| Priority date | Oct 11, 2016 |
| Publication date | Nov 13, 2018 |
| Grant date | Nov 13, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A functionalized magnetic nanoparticle including an organometallic sandwich compound and a magnetic metal oxide. The functionalized magnetic nanoparticle may be reacted with a metal precursor to form a catalyst for various C—C bond forming reactions. The catalyst may be recovered with ease by attracting the catalyst with a magnet.
Opening claim text (preview).
The invention claimed is: 1. A complex represented by Formula (IA), Formula (IB), Formula (IIA), or Formula (IIB), a solvate, or a stereoisomer thereof, wherein Formula (IA), Formula (IB), Formula (IIA), or Formula (IIB) are: where each of R 1 , R 2 , R 3 , R 4 , and R 5 is independently a hydrogen, an optionally substituted alkyl, an optionally substituted cycloalkyl, an optionally substituted aryl, or an optionally substituted arylalkyl; R 5 ′ is a hydrogen, hydroxy, cyano, nitro, an optionally substituted alkyl, an optionally substituted cycloalkyl, an optionally substituted aryl, an optionally substituted arylalkyl, an optionally substituted alkoxy, an optionally substituted cycloalkyloxy, an optionally substituted aryloxy, an optionally substituted arylalkoxy, or an optionally substituted carbamyl; each of R 6 and R 7 is independently a hydrogen, cyano, nitro, an optionally substituted alkyl, an optionally substituted cycloalkyl, an optionally substituted aryl, an optionally substituted arylalkyl, an optionally substituted alkoxy, an optionally substituted cycloalkyloxy, an optionally substituted aryloxy, an optionally substituted arylalkoxy, or an optionally substituted carbamyl; each of R 8 is an optionally substituted alkyl, an optionally substituted cycloalkyl, an optionally substituted aryl, or an optionally substituted arylalkyl; a and b are independently an integer in a range of 1-10; X is O or NH; M is selected from the group consisting of chromium, nickel, iron, lead, ruthenium, and rhodium; and W is an optionally substituted arylene. 2. The complex of claim 1 , wherein M is iron. 3. The complex of claim 1 , wherein R 1 is an optionally substituted alkyl. 4. The complex of claim 1 , wherein R 8 is an optionally substituted aryl. 5. The complex of claim 1 , wherein X is NH. 6. The complex of claim 1 , which is: 7. A functionalized magnetic nanoparticle, comprising: a complex represented by Formula (IIIA), Formula (IIIB), Formula (IVA), or Formula (IVB), a solvate, or a stereoisomer thereof; and a nanoparticle comprising at least one magnetic metal oxide selected from the group consisting of nickel(II) oxide, chromium(IV) oxide, manganese(II) oxide, manganese(III) oxide, iron(II) oxide, and iron(III) oxide; wherein the complex represented by Formula (IIIA), Formula (IIB), Formula (IVA), or Formula (IVB) is: where each of R 1 , R 3 , and R 4 is independently a hydrogen, an optionally substituted alkyl, an optionally substituted cycloalkyl, an optionally substituted aryl, or an optionally substituted arylalkyl; each of R 6 and R 7 is independently a hydrogen, cyano, nitro, an optionally substituted alkyl, an optionally substituted cycloalkyl, an optionally substituted aryl, an optionally substituted arylalkyl, an optionally substituted alkoxy, an optionally substituted cycloalkyloxy, an optionally substituted aryloxy, or an optionally substituted carbamyl; each of R 5 is an optionally substituted alkyl, an optionally substituted cycloalkyl, an optionally substituted aryl, or an optionally substituted arylalkyl; R 9 is a single bond, a hydrogen, an optionally substituted alkyl, an optionally substituted cycloalkyl, an optionally substituted aryl, or an optionally substituted arylalkyl; R 9 is a —O—, hydrogen, hydroxy, cyano, nitro, an optionally substituted alkyl, an optionally substituted cycloalkyl, an optionally substituted aryl, an optionally substituted arylalkyl, an optionally substituted alkoxy, an optionally substituted cycloalkyloxy, an optionally substituted aryloxy, an optionally substituted arylalkoxy, or an optionally substituted carbamyl; a and b are independently an integer in a range of 1-10; X is O or NH; M is selected from the group consisting of chromium, nickel, iron, lead, ruthenium, and rhodium; W is an optionally substituted arylene; and wherein an oxygen atom in —OR 9 group in the complex represented by Formula (IIIA), Formula (IIIB), Formula (IVA), or Formula (IVB) is bound to a surface of the nanoparticle. 8. The functionalized magnetic nanoparticle of claim 7 , wherein the nanoparticle comprises iron(II) oxide and iron(III) oxide. 9. The functionalized magnetic nanoparticle of claim 7 , wherein the nanoparticle has an average diameter in a range of 1-20 nm. 10. The functionalized magnetic nanoparticle of claim 7 , wherein R 1 is an optionally substituted alkyl. 11. The functionalized magnetic nanoparticle of claim 7 , wherein R 8 is an optionally substituted aryl. 12. The functionalized magnetic nanoparticle of claim 7 , wherein the functionalized magnetic nanoparticle has a saturation magnetization in a range of 40-70 emu/g. 13. A catalyst, comprising: a reaction product of the functionalized magnetic nanoparticle of claim 7 and a palladium complex or a rhodium complex, wherein the catalyst comprises palladium or rhodium bound to a phosphorous atom in at least one —PR 8 2 group. 14. The catalyst of claim 13 , wherein the catalyst has a saturation magnetization in a range of 30-70 emu/g. 15. The catalyst of claim 13 , wherein the catalyst retains at least 90% of an initial catalytic activity when the catalyst is reused. 16. A hydroformylation method, comprising: reacting an optionally substituted alkene with carbon monoxide and hydrogen in the presence of the catalyst of claim 13 and optionally a solvent thereby forming an aldehyde, wherein the catalyst comprises rhodium bound to the phosphorous atom in the at least one —PR 8 2 group. 17. The method of claim 16 , wherein: the reacting is carried out at a pressure in a range of 100-1,000 psi for 5-20 hours at a temperature in a range of 40-80° C. the solvent is present; and the solvent comprises DCM, THF, or both. 18. The method of claim 16 , further comprising separating the catalyst from the aldehyde; and reusing the catalyst. 19. A Mizoroki-Heck coupling method, comprising: reacting an optionally substituted styrene with an aryl halide in the presence of the catalyst of claim 13 , a solvent, and a base thereby forming a coupling product, wherein the catalyst comprises palladium bound to the phosphorous atom in the at least one —PR 8 2 group. 20. The method of claim 19 , wherein: the reacting is carried out at a temperature in a range of 50-100° C. for 10 minutes to 30 hours; the solvent comprises at least one selected from the group consisting of DMF, water, and toluene; and the base comprises at least one selected from the group consisting of an alkali metal hydroxide, an alkali metal carbonate, and an amine.
of the platinum group metals, iron group metals or copper · CPC title
the impregnation liquid containing organic compounds · CPC title
of ultrasonic wave energy · CPC title
comprising aliphatic or saturated rings · CPC title
Linker or spacer groups · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.